Mometason Adgc (Mometasone Furoate Monohydrate)

Mometasone furoate monohydrate, the active ingredient in Mometason Adgc, is a corticosteroid presented as a nasal formulation for intranasal use. It reduces inflammation in the nasal passages and is indicated for the treatment of allergic rhinitis in adults and children.

GNH USA supplies Mometason Adgc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches, regulatory compliance across global markets, and reliable logistics for timely delivery.

Mometason Adgc is a nasal corticosteroid used to manage inflammatory conditions of the nasal mucosa. - Allergic rhinitis: relief of nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: control of symptoms during pollen exposure periods. - Perennial allergic rhinitis: reduction of chronic nasal inflammation and symptom burden.

Mometason Adgc may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Sore throat. - Altered taste or oral discomfort.

Serious or Rare Side Effects: - Nasal septal perforation. - Adrenal suppression with systemic effects. - Vision changes such as cataracts or glaucoma. - Severe allergic reaction (anaphylaxis).

Before using Mometason Adgc, consider the following safety points. - Pregnancy: consult a healthcare professional before use. - Pediatric use: safety not established in children under two years of age. - Active nasal infection: avoid use until infection resolves. - Surgical patients: inform the surgeon as the spray may increase bleeding risk. - Long‑term therapy: monitor for signs of systemic corticosteroid exposure. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometason Adgc can interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance overall allergy symptom control. - Nasal decongestants: additive risk of local irritation. - Antifungal nasal sprays: potential for increased mucosal irritation. - Live vaccines: possible reduced immune response if systemic absorption occurs.